Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Transcutaneous Electrical Nerve Stimulation for Acute Low Back Pain in EDs

Official title: Treatment of Acute Low Back Pain With Transcutaneous Electrical Neurostimulation in Emergency Departments: a Randomised Controlled Trial

Run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · NCT07588490 · Data updated 2026-11-12

This trial tests whether TENS can relieve acute low back pain in adults who come to the emergency department.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment222 (estimated)
SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain
Academic / other
Locations1 site (Brussels)
StatusRecruiting
StartedJanuary 12, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 14, 2026
Trial IDNCT07588490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with acute low back pain treated in the emergency department and not meeting exclusion criteria.

Probably not a fit

Patients with chronic back pain, trauma-related pain, infections, inflammatory diseases, or prior TENS treatment may not benefit or could be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with acute low back pain presenting to the ED will be randomized to receive active TENS or a sham/FAKE TENS intervention. The study aims to see if non-pharmacological, painless electrical stimulation can reduce pain quickly when NSAIDs and muscle relaxants have limited benefit. TENS is applied via skin electrodes to activate specific nerves and may increase endorphin levels, potentially providing analgesia without systemic drugs. The trial will monitor pain levels and safety outcomes to determine if TENS is a viable option for ED management of this condition.

Why it matters

Potential benefit: If successful, TENS could provide a non-drug option to relieve acute low back pain in the ED.

How similar studies have gone: Previous non-drug approaches like TENS have shown variable analgesic effects; this study adds rigorous ED-based evaluation to clarify its usefulness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* = or \> 18 years old
* pain (EN \> 3) related to acute lower back pain in the emergency department.

Exclusion Criteria:

* Refusal to participate in the study, refusal to sign the informed consent form
* Consent cannot be obtained (cognitive impairment, language barrier, etc.)
* Patients with lower back pain lasting more than 6 weeks
* Taking immediate-release pain medication within the last 6 hours
* Taking extended-release pain medication within the last 12 hours
* Taking a muscle relaxant within the last 24 hours
* Pregnant women
* Patients requiring immediate medical attention (life-threatening situation)
* Patient already treated with TENS
* Patient with a body temperature \> 38°C
* Patient with a known spinal infection
* Lower back pain related to trauma
* Patient with a known systemic rheumatological or spinal disease
* Patient with a known systemic inflammatory disease
* Patient with a known chronic pain condition such as fibromyalgia
* Patient with pain radiating into the lower limb along the path of one of the following nerves (L3-L4-L5-S1)

Where it's running

  • Cliniques Universitaires Saint-Luc
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.